Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page
- Check7 days agoChange DetectedThe study record history now shows a new revision entry v3.7.0 and removes the previous v3.6.6 entry, updating the version history to reflect the latest documentation update.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNew revision entry v3.6.6 was added to the study record history, and the previous revision v3.6.5 was removed. This update reflects an adjustment to the version log within the study's history page.SummaryDifference0.1%

- Check35 days agoChange DetectedThe sponsor decided to rollover the remaining participants to study PHA022121-C307. The trial was terminated and results were posted, with corresponding updates to Study Status and Outcome Measures.SummaryDifference0.5%

- Check49 days agoChange DetectedThe page's revision label updated from v3.6.4 to v3.6.5, indicating a new version of the page. This change is limited to metadata and does not modify substantive content or functionality.SummaryDifference0.1%

- Check56 days agoChange DetectedThe latest version shows the submission was returned on 2026-07-28 and is under Quality Control Review, with the study history updated to include key sections such as Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, and Study/Recruitment Status.SummaryDifference0.9%

- Check63 days agoChange DetectedThe study record history adds a new revision tag v3.6.4 and removes the previous v3.6.3, reflecting a newer update to the record.SummaryDifference0.1%

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.